Chu‐Huang Chen

4.6k total citations · 1 hit paper
111 papers, 3.4k citations indexed

About

Chu‐Huang Chen is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Chu‐Huang Chen has authored 111 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 35 papers in Molecular Biology and 32 papers in Surgery. Recurrent topics in Chu‐Huang Chen's work include Atherosclerosis and Cardiovascular Diseases (40 papers), Lipoproteins and Cardiovascular Health (23 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). Chu‐Huang Chen is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (40 papers), Lipoproteins and Cardiovascular Health (23 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). Chu‐Huang Chen collaborates with scholars based in Taiwan, United States and Japan. Chu‐Huang Chen's co-authors include Liang‐Yin Ke, Gopal K. Marathe, Jonathan Lu, Shi‐Hui Law, Farzana Parveen, Tatsuya Sawamura, Philip D. Henry, Po‐Yuan Chang, Chih‐Sheng Chu and Chao-Yuh Yang and has published in prestigious journals such as Nucleic Acids Research, Circulation and Blood.

In The Last Decade

Chu‐Huang Chen

108 papers receiving 3.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases

2019 512 citations Gopal K. Marathe, Chu‐Huang Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chu‐Huang Chen Taiwan	32	1.3k	1.0k	861	491	441	111	3.4k
Veronika A. Myasoedova Italy	31	1.3k 1.1×	1.1k 1.1×	922 1.1×	904 1.8×	707 1.6×	106	4.4k
Lillemor Mattsson Hultén Sweden	28	1.1k 0.9×	942 0.9×	920 1.1×	504 1.0×	606 1.4×	74	3.2k
Alexandra А. Melnichenko Russia	25	1.1k 0.8×	738 0.7×	623 0.7×	445 0.9×	450 1.0×	74	2.8k
Carmen Gómez‐Guerrero Spain	40	1.5k 1.2×	1.3k 1.3×	481 0.6×	466 0.9×	461 1.0×	92	4.5k
Ewa Ninio France	37	1.4k 1.1×	1.0k 1.0×	1.2k 1.3×	576 1.2×	748 1.7×	103	4.1k
Víctor Grijalva United States	33	1.0k 0.8×	495 0.5×	1.1k 1.3×	372 0.8×	407 0.9×	59	3.7k
Gopal K. Marathe United States	32	1.5k 1.2×	702 0.7×	466 0.5×	246 0.5×	410 0.9×	69	3.3k
Qingwei Zhao China	31	1.4k 1.1×	671 0.6×	565 0.7×	493 1.0×	411 0.9×	98	3.5k
Eva Hurt‐Camejo Sweden	42	1.8k 1.4×	1.2k 1.1×	1.5k 1.7×	623 1.3×	793 1.8×	92	4.8k
José Tuñón Spain	39	1.6k 1.3×	908 0.9×	1.3k 1.5×	1.4k 2.9×	634 1.4×	144	4.8k

Countries citing papers authored by Chu‐Huang Chen

Since Specialization

Citations

This map shows the geographic impact of Chu‐Huang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu‐Huang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu‐Huang Chen more than expected).

Fields of papers citing papers by Chu‐Huang Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chu‐Huang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu‐Huang Chen. The network helps show where Chu‐Huang Chen may publish in the future.

Co-authorship network of co-authors of Chu‐Huang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chu‐Huang Chen. A scholar is included among the top collaborators of Chu‐Huang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu‐Huang Chen. Chu‐Huang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Wen‐Li, et al.. (2025). Dysfunctional high-density lipoprotein: an updated review. Frontiers in Cardiovascular Medicine. 12. 1713387–1713387.

Chen, Po‐Ku, Wei‐Fan Hsu, Cheng‐Yuan Peng, et al.. (2024). Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis. Frontiers in Medicine. 11. 1347268–1347268. 1 indexed citations

Chen, Chu‐Huang, et al.. (2023). Selenium Ameliorates Acetaminophen-Induced Oxidative Stress via MAPK and Nrf2 Pathways in Mice. Biological Trace Element Research. 202(6). 2598–2615. 7 indexed citations

Kawashima, Hidekazu, Atsushi Nakano, Akemi Kakino, et al.. (2022). NanoSPECT imaging reveals the uptake of 123I-labelled oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36. Cardiovascular Research. 119(4). 1008–1020. 5 indexed citations

Chen, Der‐Yuan, Tatsuya Sawamura, Richard A. F. Dixon, José Luís Sánchez-Quesada, & Chu‐Huang Chen. (2021). Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies. Journal of Clinical Medicine. 10(9). 1992–1992. 8 indexed citations

Lin, Kuan‐Chou, Lai‐Lei Ting, Chia‐Lun Chang, et al.. (2021). Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer. Cancers. 13(23). 6076–6076. 31 indexed citations

Marathe, Gopal K., et al.. (2020). Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling. Prostaglandins & Other Lipid Mediators. 151. 106478–106478. 5 indexed citations

Hung, Chih‐Hsien, Cheng‐Han Lee, Ming‐Hsien Tsai, et al.. (2020). Activation of acid-sensing ion channel 3 by lysophosphatidylcholine 16:0 mediates psychological stress-induced fibromyalgia-like pain. Annals of the Rheumatic Diseases. 79(12). 1644–1656. 46 indexed citations

Ke, Liang‐Yin, Hua‐Chen Chan, Chih‐Sheng Chu, et al.. (2019). Electronegative low‐density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade. Journal of Diabetes Investigation. 11(3). 535–544. 6 indexed citations

10.

Lee, An‐Sheng, Wei‐Yu Chen, Hua‐Chen Chan, et al.. (2017). Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease. Scientific Reports. 7(1). 40676–40676. 6 indexed citations

11.

Wang, Yu-Chen, et al.. (2016). Age-dependent impact of new ESC-Guideline recommended door-to-balloon times on mid-term survival in acute ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. International Journal of Cardiology. 222. 242–246. 9 indexed citations

12.

Wang, Guei‐Jane, Chin‐Chi Kuo, Ju‐Yi Hsieh, et al.. (2016). Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis. Medicine. 95(2). e2265–e2265. 14 indexed citations

13.

Shen, Ming‐Yi, Jing‐Fang Hsu, Ru‐Huei Fu, et al.. (2015). Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. Blood. 127(10). 1336–1345. 70 indexed citations

14.

Lee, Hsiang‐Chun, et al.. (2015). Atherogenic Very-Low-Density Lipoprotein Shortens Atrial Action Potential Duration by Increasing Potassium Currents and Calcium Transient. Biophysical Journal. 108(2). 586a–586a. 1 indexed citations

15.

Hsu, Jing‐Fang, Tzu‐Chieh Chou, Jonathan Lu, et al.. (2014). Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor. PLoS ONE. 9(9). e107340–e107340. 24 indexed citations

16.

Chang, Chiz-Tzung, Chia‐Ming Chang, Chu‐Huang Chen, et al.. (2012). Oxidized ApoC1 on MALDI-TOF and glycated-ApoA1 band on gradient gel as potential diagnostic tools for atherosclerotic vascular disease. Clinica Chimica Acta. 420. 69–75. 21 indexed citations

17.

Chan, Hua‐Chen, Liang‐Yin Ke, An‐Sheng Lee, et al.. (2012). Abstract 9753: Highly Electronegative LDL is Elevated in Patients With Acute Myocardial Infarction and Triggers Platelet Activation and Aggregation. Circulation. 126(suppl_21). 1 indexed citations

18.

Lee, An‐Sheng, Jenny Wang, Hua‐Chen Chan, et al.. (2012). ELECTRONEGATIVE LOW-DENSITY LIPOPROTEIN INDUCES CARDIOMYOCYTE APOPTOSIS THROUGH A CHEMOKINE-CYTOKINE CROSSTALK MECHANISM. Journal of the American College of Cardiology. 59(13). E1000–E1000. 1 indexed citations

19.

Chang, Po‐Yuan, Shao‐Chun Lu, Ta‐Chen Su, et al.. (2004). Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. Journal of Lipid Research. 45(11). 2116–2122. 78 indexed citations

20.

Chen, Chu‐Huang, et al.. (2000). Medicinal Foods: Cross-Cultural Perspectives. Drugs & Society. 15(1-2). 49–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact